APATINIB

Clinical trials for APATINIB explained in plain language.

Never miss a new study

Get alerted when new APATINIB trials appear

Sign up with your email to follow new studies for APATINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New combo therapy shows promise for advanced liver cancer patients

Disease control Recruiting now

This study tests whether adding two drugs (camrelizumab and apatinib) to a standard liver cancer treatment called TACE can help people with liver cancer that cannot be surgically removed. About 101 adults with intermediate or advanced liver cancer will be randomly assigned to rec…

Matched conditions: APATINIB

Phase: PHASE3 • Sponsor: Guohui Xu • Aim: Disease control

Last updated Jun 07, 2026 20:33 UTC

APATINIB

Get alerted when new APATINIB trials appear

New combo therapy shows promise for advanced liver cancer patients